HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity.

AbstractAIMS/HYPOTHESIS:
Insulin controls glucose metabolism via multiple signalling pathways, including the phosphatidylinositol 3-kinase (PI3K) pathway in muscle and adipose tissue. The protein/lipid phosphatase Pten (phosphatase and tensin homologue deleted on chromosome 10) attenuates PI3K signalling by dephosphorylating the phosphatidylinositol 3,4,5-trisphosphate generated by PI3K. The current study was aimed at investigating the effect of haploinsufficiency for Pten on insulin-stimulated glucose uptake.
MATERIALS AND METHODS:
Insulin sensitivity in Pten heterozygous (Pten(+/-)) mice was investigated in i.p. insulin challenge and glucose tolerance tests. Glucose uptake was monitored in vitro in primary cultures of myocytes from Pten(+/-) mice, and in vivo by positron emission tomography. The phosphorylation status of protein kinase B (PKB/Akt), a downstream signalling protein in the PI3K pathway, and glycogen synthase kinase 3beta (GSK3beta), a substrate of PKB/Akt, was determined by western immunoblotting.
RESULTS:
Following i.p. insulin challenge, blood glucose levels in Pten(+/-) mice remained depressed for up to 120 min, whereas glucose levels in wild-type mice began to recover after approximately 30 min. After glucose challenge, blood glucose returned to normal about twice as rapidly in Pten(+/-) mice. Enhanced glucose uptake was observed both in Pten(+/-) myocytes and in skeletal muscle of Pten(+/-) mice by PET. PKB and GSK3beta phosphorylation was enhanced and prolonged in Pten(+/-) myocytes.
CONCLUSIONS/INTERPRETATION:
Pten is a key negative regulator of insulin-stimulated glucose uptake in vitro and in vivo. The partial reduction of Pten due to Pten haploinsufficiency is enough to elicit enhanced insulin sensitivity and glucose tolerance in Pten(+/-) mice.
AuthorsJ T Wong, P T W Kim, J W Peacock, T Y Yau, A L-F Mui, S W Chung, V Sossi, D Doudet, D Green, T J Ruth, R Parsons, C B Verchere, C J Ong
JournalDiabetologia (Diabetologia) Vol. 50 Issue 2 Pg. 395-403 (Feb 2007) ISSN: 0012-186X [Print] Germany
PMID17195063 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Glucose Transporter Type 1
  • Glucose Transporter Type 4
  • Insulin
  • Slc2a1 protein, mouse
  • Slc2a4 protein, mouse
  • Fluorodeoxyglucose F18
  • Deoxyglucose
  • Phosphatidylinositol 3-Kinases
  • PTEN Phosphohydrolase
  • Glucose
Topics
  • Animals
  • Blood Glucose (drug effects, metabolism)
  • Crosses, Genetic
  • Deoxyglucose (metabolism)
  • Diabetes Mellitus, Type 2 (genetics)
  • Fluorodeoxyglucose F18
  • Genetic Carrier Screening
  • Glucose (pharmacology)
  • Glucose Tolerance Test
  • Glucose Transporter Type 1 (metabolism)
  • Glucose Transporter Type 4 (metabolism)
  • Insulin (blood, pharmacology)
  • Insulin-Secreting Cells (metabolism)
  • Islets of Langerhans (drug effects, metabolism)
  • Mice
  • PTEN Phosphohydrolase (deficiency, genetics, metabolism)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Positron-Emission Tomography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: